Improved diagnoses of autoimmune hepatitis using an anti-actin ELISA

Journal of Clinical Laboratory Analysis

Volumn 22, Issue 5, 2008, Pages 340-345

  Aubert, Vincent ^a   Pisler, Isabelle Graf ^a   Spertini, François ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Actin; Antibodies; Autoimmune hepatitis; Evaluation; Immunofluorescence

Indexed keywords

ACTIN ANTIBODY; F ACTIN; SMOOTH MUSCLE ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; VIRUS HEPATITIS;

ACTINS; ANIMALS; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS, AUTOIMMUNE; HUMANS; MICE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

HEPATITIS C VIRUS;

EID: 53549122754     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20274     Document Type: Article

References (20)

1. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 1996;24:1068-1073.
2. Johnson PJ, McFarlane IG. Meeting report: International autoimmune hepatits group. Hepatology 1993;18:998-1005.
3. Johnson PJ, McFarlane IG, Eddleston ALWF. The natural course and heterogeneity of autoimmune-type chronic active hepatitis. Semin Liver Dis 1991;11:187-196.
4. Bylund D, McHutchinson J. Autoimmune liver diseases. Clin Lab Med 1997;17:483-497.
5. Smalley DL, Hall MF, Broughton CL. Autoantibodies present in chronic hepatitis C and chronic hepatitis B viral infections. Hepatology 1998;27:1452-1453.
6. Leibovitch L, George J, Levi Y, Bakimer R, Shoenfeld Y. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunol Lett 1995;48:129-132.
7. e édition. Paris: Elsevier Collection Option Bio. 1997.
8. Zamanou A, Tsirogianni A, Terzoglou C, Balafas A, Economidou I, Lymberi P. Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: A comparison of classical indirect immunofluorescence with ELISA. J Clin Lab Anal 2002;16:194-201.
9. Granito A, Muratori L, Muratori P, et al. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol 2006;59:280-284.
10. Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 1999;30:394-401.
11. Abuaf N, Lunel F, Giral P, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993;18:349-364.
12. Clifford BD, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-619.
13. Chazouilleres O, Johanet C, Serfaty L, et al. Anti-actin autoantibodies in patients with chronic hepatitis C. J Hepatol 1996;24:513.
14. Chretien-Leprince P, Ballot E, Andre C, et al. Diagnostic value of anti-F-actin antibodies in a French multicenter study. Ann NY Acas Sci 2005;1050:266-273.
15. Cassani F, Cataleta M, Valentini P, et al. Serum antoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997;26:561-566.
16. Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, Gershwin ME. T cell immunity in autoimmune hepatitis. Autoimmun Rev 2005;4:315-321.
17. Dumoulin FL, Leifeld L, Sauerbruch T, Spengler U. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother 1999;53:242-254.
18. Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 1995;108:1159-1166.
19. Orth T, Gerken G, Kellner R, Meyer zum Büschenfelde K-H, Mayet W-J. Actin is target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1. J Hepatol 1997;26:37-47.
20. Silvestrini RA, Benson EM. Whither smooth muscle antibodies in the third millennium? J Clin Pathol 2001;54:677-678.